Hydrochlorothiazide/Valsartan

氢氯噻嗪/缬沙坦

Report date: 2025/01/07 11:28:52

Base Information

Drug NameHydrochlorothiazide/Valsartan
Drug Alias Name缬沙坦/氢氯噻嗪Hydrochlorothiazide and Valsartanvalsartan and hydrochlorothiazide缬沙坦氢氯噻嗪Valsartan - hydrochlorothiazide +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin II Receptor Type 1 antagonists
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1998/03/06
Country/TerritoryUnited StatesGermanySwitzerland +[5] 
CombinationsYes HydrochlorothiazideValsartan
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DA03
Related LinksWikipediaKEGG